RWA
RDY icon

Redhawk Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Redhawk Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-73,710
Closed -$1.08M – 334
2024
Q1 		$1.08M Buy
+73,710
New +$1.08M 0.18% 112

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redhawk Wealth Advisors's RDY Position: Q2 2024 in Review

Redhawk Wealth Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 73,710 shares — an estimated $1.08M sold.

Redhawk Wealth Advisors first reported a position in RDY in Q1 2024 and held it in 1 quarter. The position peaked at $1.08M in Q1 2024. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Redhawk Wealth Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 73,710 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $1.08M.
  • Redhawk Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2024 and held it in 1 quarter.
  • Redhawk Wealth Advisors's Dr. Reddy's Laboratories position peaked at $1.08M in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2024, filed 16 Jul 2024.